InvestorsHub Logo
Followers 25
Posts 1133
Boards Moderated 0
Alias Born 04/04/2012

Re: Clockonthewall post# 858

Thursday, 12/03/2020 6:23:35 PM

Thursday, December 03, 2020 6:23:35 PM

Post# of 894
Merrimack sold its oncology portfolio to Ipsen in April 2017 for $575M in upfront cash. MACK is eligible to receive up to an additional $450M triggered by the approval of additional indications for Onivyde in the U.S., a bullish prospect considering its current market cap of ~$77M.

https://seekingalpha.com/news/3640924-merrimack-pharma-jumps-42-on-bullish-timeline-for-potential-onivyde-milestone-payment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MACK News